RRML - Biomarkers in heart failure: from the bedside back to biology
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Română English


Journal Metrics

Impact Factor 0.493
Five Year Impact Factor 0.531
SNIP 0.373
JCI 0.17


Advanced search


Top 10 downloaded articles
- September 2022 -
 
Downregulation of hsa-miR-4328... 15
Normality assessment, few para... 11
SPP1 is a biomarker of cervica... 9
Biomarkers in heart failure: f... 8
Validation of GOD / PAP method... 7
The effect of Ulva rigida (C. ... 7
Expressions of TGF-β1 and VEG... 7
COVID-19 associated coagulopat... 6
Approaching Risk Management in... 6
Expression of serum soluble Kl... 6

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 26(3)/2018 DOI:10.2478/rrlm-2018-0031
XML
TXT

Editorial

Biomarkers in heart failure: from the bedside back to biology

Yasmin Rustamova, Dan Dobreanu

Correspondence should be addressed to: Dan Dobreanu

Received: 12.7.2018
Accepted: 18.7.2018
Published: 18.7.2018

 
  PDF Download full text PDF
(292 KB)
     
 
How to cite
Rustamova Y, Dobreanu D. Biomarkers in heart failure: from the bedside back to biology. Rev Romana Med Lab. 2018;26(3):267-70. DOI:10.2478/rrlm-2018-0031